Huadong Medicine Co., Ltd (SHE:000963)
36.21
+0.32 (0.89%)
Feb 3, 2026, 2:35 PM CST
Huadong Medicine Market Cap
Huadong Medicine has a market cap or net worth of 62.8 billion as of February 2, 2026. Its market cap has increased by 9.41% in one year.
Market Cap
62.80B
Enterprise Value
61.07B
Revenue
43.09B
Ranking
n/a
PE Ratio
17.04
Stock Price
36.21
Market Cap Chart
Since January 2, 2001, Huadong Medicine's market cap has increased from 4.21B to 62.80B, an increase of 1,391.58%. That is a compound annual growth rate of 11.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 62.80B | -9.02% |
| Dec 31, 2025 | 69.03B | 14.00% |
| Dec 31, 2024 | 60.55B | -16.55% |
| Dec 29, 2023 | 72.56B | -11.60% |
| Dec 30, 2022 | 82.09B | 16.70% |
| Dec 31, 2021 | 70.34B | 51.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Biokin Pharmaceutical | 114.68B |
| Yunnan Baiyao Group Co.,Ltd | 99.22B |
| Zhejiang NHU Company | 85.21B |
| Shanghai Fosun Pharmaceutical (Group) | 65.80B |
| Shenzhen Salubris Pharmaceuticals | 52.30B |
| China Resources Sanjiu Medical & Pharmaceutical | 46.78B |
| Beijing Tongrentang | 41.58B |
| Changchun High-Tech Industry (Group) | 38.64B |